Eric Venker, President & Immunovant CEO: Roivant Sciences ROIV Sell · Filed 06/26

Trade details

Type: Insider sale
Amount: $1,549,301.34
Shares · price: 46,234 sh · $33.51 a share
Held after: 1,613,063 sh
Stock: Roivant Sciences ROIV
Person: Eric VenkerPresident & Immunovant CEO
Trade date: 26/06/24
Filed: 26/06/26
Days to filing: 2 days

Sold 2.8% of holdings

Share of holding sold: 2.8%

Roivant Sciences trades, last 26 weeks

What else happened in Roivant Sciences around then

Filed or reported within 30 days of the trade day · 05/25~07/24

Eric Venker's recent trades

Eric VenkerPresident & Immunovant CEO
Sell10b5-1 planRoivant Sciences
Sell10b5-1 plan
Roivant Sciences
ROIV
$7.3M
200,000 sh
$7.3M
Filed 10/02
Traded 09/30
Eric VenkerPresident & Immunovant CEO
Planned sale10b5-1 planRoivant Sciences
Planned sale10b5-1 plan
Roivant Sciences
ROIV
$7.3M
200,000 sh
$7.3M
Filed 09/30
Traded 09/30
Eric VenkerPresident & Immunovant CEO
Planned sale10b5-1 planRoivant Sciences
Planned sale10b5-1 plan
Roivant Sciences
ROIV
$7.1M
200,000 sh
$7.1M
Filed 08/28
Traded 08/28
Eric VenkerPresident & Immunovant CEO
Planned sale10b5-1 planRoivant Sciences
Planned sale10b5-1 plan
Roivant Sciences
ROIV
$7M
200,000 sh
$7M
Filed 07/27
Traded 07/27
Eric VenkerPresident & Immunovant CEO
Sell10b5-1 planRoivant Sciences
Sell10b5-1 plan
Roivant Sciences
ROIV
$5.1M
153,766 sh
$5.1M
Filed 06/26
Traded 06/24

Eric Venker, CEO — sold $1.5M of Roivant Sciences ROIV · 2.8% of holdings · 10b5-1 plan | Whalegun